Wacker Chemie invested a multi-million euro sum to inaugurate its Biotechnology Center in Munich, consolidating biotech R&D activities focused on bioprocess development for proteins and nucleic acids production. The facility aims to expedite translation from foundational research to market-ready solutions, optimizing efficiency and speed to market amid competitive pressures. The new center also supports development of innovative food and supplement ingredients, underscoring Wacker’s strategic commitment to growth in biotechnology despite broader economic challenges.